A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Public ClinicalTrials.gov record NCT01371708. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 6-month, Open-label, Multi-center, Flexible Dose Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a 6-month, open-label, flexible-dose study evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in the Treatment of Child and Adolescent Outpatients with Major Depressive Disorder (MDD).
Study identification
- NCT ID
- NCT01371708
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 283 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 7 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2, 2012 (Actual)
- Primary completion
- Apr 22, 2016 (Actual)
- Completion
- Apr 22, 2016 (Actual)
- Last update posted
- Jul 27, 2017
2012 – 2016
United States locations
- U.S. sites
- 35
- U.S. states
- 19
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The University Of Alabama At Birmingham, Office Of Psychiatric Research | Birmingham | Alabama | 35294-0009 | — |
| Center for Advanced Improvement | Tucson | Arizona | 85719 | — |
| Sun Valley Research Center | Imperial | California | 92251 | — |
| MCB Clinical Research Centers | Colorado Springs | Colorado | 80910 | — |
| Institute of Living/Hartford Hospital | Hartford | Connecticut | 06106 | — |
| SJS Clinical Research, Inc. | Destin | Florida | 32541 | — |
| Sarkis Clinical Trials | Gainesville | Florida | 32607 | — |
| Clinical Neuroscience Solutions | Jacksonville | Florida | 32256 | — |
| Medical Research Group of Central Florida | Orange City | Florida | 32763 | — |
| Millenia Psychiatry & Research, Inc. | Orlando | Florida | 32839 | — |
| Janus Center for Psychiatric Research | West Palm Beach | Florida | 33407 | — |
| Northwest Behavioral Research Center | Marietta | Georgia | 30060 | — |
| Capstone Clinical Research | Libertyville | Illinois | 60048 | — |
| Baber Research Group | Naperville | Illinois | 60563 | — |
| Clinco | Terre Haute | Indiana | 47802 | — |
| Pharmasite Research, Inc | Baltimore | Maryland | 21208 | — |
| Millennium Psychiatric Associates, LLC | Creve Coeur | Missouri | 63141 | — |
| Premier Psychiatric Research Institute, LLC | Lincoln | Nebraska | 68526 | — |
| Erie County Medical Center/State University of New York (SUNY) at Buffalo Affiliate | Buffalo | New York | 14215 | — |
| The Zucker Hillside Hospital, North Shore-Long Island Jewish Health System | Glen Oaks | New York | 11004 | — |
| Bioscience Research, LLC. | Mount Kisco | New York | 10549 | — |
| Finger Lakes Clinical Research | Rochester | New York | 14618 | — |
| Stony Brook University Medical Center, child and Adolescent Psychiatry | Stony Brook | New York | 11794-8790 | — |
| Neuro-Behavioral Clinical Research, Inc. | Canton | Ohio | 44718 | — |
| Discovery and Wellness Center for Children/University Hospitals Case Medical Center | Cleveland | Ohio | 44106 | — |
| Sooner Clinical Research | Oklahoma City | Oklahoma | 73112 | — |
| Research Strategies of Memphis, LLC. | Memphis | Tennessee | 38119 | — |
| FutureSearch Trials | Austin | Texas | 78731 | — |
| Clinical Trials of Texas, Inc. | San Antonio | Texas | 78229 | — |
| Clinical Trials of Texas, INC | San Antonio | Texas | 78229 | — |
| Allance Research Group | Richmond | Virginia | 23230 | — |
| Alliance Research Group | Richmond | Virginia | 23230 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298 | — |
| Virginia Treatment Center for Children | Richmond | Virginia | 23298 | — |
| Eastside Therapeutic Resource | Kirkland | Washington | 98033 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01371708, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 27, 2017 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01371708 live on ClinicalTrials.gov.